Acute Lymphoblastic Leukemia: Optimizing MRD Testing

0 Views
administrator
administrator
06/15/23

Mark R. Litzow, MD; Anthony S. Stein, MD; Aaron C. Logan, MD, PhD; and Bijal D. Shah, MD, reflect on the optimal time to test for minimal residual disease and how to best interpret the results regarding the prognosis of a patient with acute lymphoblastic leukemia.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next